These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The dosage-performance effects on Ca-Ski and HPK cells in relation to the dose and fractionation].
    Author: Schulz-Wendtland R, Krämer S, Keilholz L, Pflüger S, Lang N.
    Journal: Strahlenther Onkol; 1996 Aug; 172(8):439-45. PubMed ID: 8765347.
    Abstract:
    BACKGROUND: The steep decrease of dose and dose-rate in brachytherapy implies very different radiobiological considerations of the biological effectivity. MATERIAL AND METHODS: Therefore, in imitation of the clinical procedure, we compared the LDR-, MDR- and HDR-brachytherapy. We carried out experiments on epidermoid cervix carcinoma cells (Ca-Ski cells) and human primary keratinocytes (HPK cells) obtained after transfection with human papillomavirus type 16 DNA varying the dose-rate (28 cGy/h to 8000 cGy/h), the dose (1 Gy to 100 Gy) and fractionating (protracted, 3, 6 and 12 fractions). RESULTS: 1. At dose-rates of 75 cGy/h (Ca-Ski cells) and 110 cGy/h (HPK cells) respectively we found that the cells "fall asleep" at doses up to 100 Gy; the rate of cell mortality is insignificantly higher than the proliferation rate. 2. A first-time proof of an accumulation of repopulation effects (recovery from the sublethal radiation damage, progression of the cells during the partial cycle/proliferation and the acts of redistribution), if the radiation exposure reaches the median time of the cell cycle (HPK cells, dose-rate: 110 cGy/h, doses: 1 Gy to 100 Gy). 3. Each increase in the dose-rate requires higher fractionating. At dose-rates higher than 300 cGy/h (range of a percutaneous radiotherapy), we found that the survival rates of the cells could only be increased insignificantly in spite of a fractionated therapy (3, 6 or 12 fractions; doses: 1 Gy to 100 Gy); the repopulation effects almost vanished. CONCLUSIONS: Changing a LDR- into an HDR-brachytherapy the equivalent factors close to the source have to be selected low and with increasing distances from the source high respectively higher-the major problem for a mathematical formula. The reduction of the dose in HDR-radiation therapy is a compromise in order to limit side effects caused by a radiation. The trade-off is a small therapeutic range and reduced therapeutic effectivity at the tumor. The percutaneous dose at the pelvis wall has to be reduced if at the same time an HDR-brachytherapy will be carried out-to avoid side effects.
    [Abstract] [Full Text] [Related] [New Search]